Banner -- Identifying Strategies to Collect Drug Usage and Driving Functioning Among Older Drivers
 

REFERENCES

Adams, W.L. (1995). “Potential for Adverse Drug-Alcohol Interactions Among Retirement Community Residents.” Journal of the American Geriatrics Society, 43, 1021-1025.

Adams, W.L., Yuan, Z., Barboriak, J.J., and Rimm, A.A. (1993). “Alcohol-Related Hospitalizations in Elderly People: Prevalence and Geographic Variation in the United States.” Journal of the American Medical Association, 270, 1222-1225.

Agency for Healthcare Research and Quality. AHRQ Patient Safety Network: Glossary. Accessed on June 7, 2005, from http://psnet.ahrq.gov/glossary.aspx.

Allard, J., Hébert, R.,, Rioux, M., Asselin, J., and Voyer, L. (2001). “Efficacy of a Clinical Medication Review on the Number of Potentially Inappropriate Prescriptions Prescribed for Community-Dwelling Elderly People.” Canadian Medical Association Journal, 164(9), 1291-1296.

Álvarez, F. J., and del R ío, C. (2003). “Illicit Drugs and Fitness to Drive: Assessment in Spanish Medical Driving Test Centers.” Drug and Alcohol Dependence, 64, 19-25.

Álvarez, F. J., and del R ío, C. (2002). “Medicinal Drugs and Driving: from Research to Clinical Practice.” Trends in Pharmacological Sciences, 23(9), 441-443.

American Society of Health-System Pharmacists. (2001). “Cardiac Drugs.” In: Drug Information 2001, 1500-1511. Bethesda, MD.

American Pharmacists Association/APhA. (2003). Medication Compliance-Adherence-Persistence (CAP) Digest. American Pharmacists Association and Pfizer Pharmaceuticals. Washington, D.C.

Aparasu, R.R. and Mort, J.R. (2004). “Prevalence, Correlates, and Associated Outcomes of Potentially Inappropriate Psychotropic Use in the Community-Dwelling Elderly.” The American Journal of Geriatric Pharmacotherapy, 2(2), 102-111.

Australian Association of Occupational Therapists—Victoria, Inc. (1998). Competency Standards for Occupational Therapy Driving Assessors. Ashburton, Victoria, Australia.

Balkrishnan, R., Rajagopalan, R., Camacho, F.T., Huston, S.A., Murray, F.T., and Anderson, R.T. (2003). “Predictors of Medication Adherence and Associated Health Care Costs in an Older Population with Type 2 Diabetes Mellitus: A Longitudinal Cohort Study.” Clinical Therapeutics, 25(11), 2958-2971.

Barat, I., Andreasen, F., and Damsgaard. (2001). “Drug Therapy in the Elderly: What Doctors Believe and Patients Actually Do.” British Journal of Clinical Pharmacology , 51(6), 615-622.

Bartlett, G., Abrahamowicz, M., Tamblyn, R., Grad, R., Capek, R., and du Berger, R. (2004). “Longitudinal Patterns of New Benzodiazepine Use In The Elderly.” Pharmacoepidemiol. Drug Saf. 13:669-682.

Beck, A. and Beck, R. (1972). “Screening Depressed Patients in Family Practice: A Rapid Technique.” Postgrad. Med., 52, 81-86.

Becker, M.H., and Maiman, L.A. (1975). “Sociobehavioral Determinants of Compliance with Health and Medical Care Recommendations.” Med Care, 13(1):10-24.

Beers, M.H. (1997). “Explicit Criteria for Determining Potentially Inappropriate Medication Use by the Elderly: An Update. Archives of Internal Medicine, 157, 1531-1536.

Behrensdorff, I., and Steentoft, A. (2002). “Medicinal and Illegal Drugs Among Danish Car Drivers.” Accident Analysis and Prevention, 25, 851-860.

Berg, J.S., Dischler, J., Wagner, D.J., Raia, J.J., and Palmer-Shevlin, N. (1993). “Medication compliance: A Healthcare Problem.” Annals of Pharmacotherapy, 27(9 Suppl), S1-24.

Berghaus, G., and Grass, H. (1997). “Concentration-Effect Relationship with Benzodiazepine Therapy. In: Proceedings—14 th International Conference on Alcohol, Drugs, and Traffic Safety. C. Mercier-Guyon, Ed. Centre d’Etudes et de Recherchers en Médeccine du Traffic, France, pp. 705-709.

Bikowski, R.M., Ripsin, C.M., and Lorraine, V.L. (2001). “Physician-Patient Congruence Regarding Medication Regimes.” Journal of the American Geriatrics Society, 49, 1353-1357.

Borkenstein, R.F., Crowther, R.F., Schumate, R.P., et al. (1964). The Role of the Drinking Driver in Traffic Accidents. Bloomington, Ind., University of Indiana, Department of Police Administration.

Brenner, S.S., Herrlinger, C., Dilger, K., Mürdter, T.E., Hofmann, U., Marx, C., and Klotz, U. (2003). “Influence of Age and Cytochrome P450 2C9 Genotype on the Steady-State Disposition of Diclofenac and Celecoxib.” Clin. Pharmacokinet. 42:283-292.

Briceland, L.L., Kane, M.P., and Hamilton, R.A. (1992). “Evaluation of Patient-Care Interventions by Pharm.D. Clerkship Students.” Am Soc Hosp Pharm, 49, 1130-1132.

Briggs, R.S., Castleden, C.M., and Kraft, C.A. (1980). “Improved Hypnotic Treatment Using Chlormethiazole and Tanzepam.” British Medical Journal, 280, 601-604.

Brody, J.A. (1984). “Alcohol and Aging: The Extent of the Problem from Limited Data.” In E.L. Autheil (ed.). Combined Problems of Alcoholism, Drug Addiction, and Aging. Springfield, IL: Charles C. Thomas.

Brouwer, W.H., Ponds, R.W., and Van Woffelaar, P.C. (1989). “Divided Attention 5-10 Years After Severe Closed Head Injury. Cortex, 25, 219-230.

Cadieux, R.J. (1989). “Drug Interactions in the Elderly. How Multiple Drug Use Increases Risk Exponentially.” Postgraduate Medicine, 86(8): 179-86.

Carr, D.B. (2004). “Commentary: The Role of the Emergency Physician in Older Driver Safety.” Annals of Emergency Medicine, 43(6), 747-748.

Carr, D., Schmader, K., Bergman, C., et al. (1991). “A Multidisciplinary Approach in the Evaluation of Demented Drivers Referred to Geriatric Assessment Centers.” Journal of the American Geriatrics Society, 39, 1132-1136.

Caskie, G., and Willis, S. (2004). “Congruence of Self-Reported Medications with Pharmacy Prescription Records in Low-Income Older Adults.” The Gerontologist, 44, 176-185.

Castellas, D.D., Teitelbaum, B.A., and Tresley, D.J. (2002). “Visual Changes Secondary to Initiation of Amiodarone: A Case Report and Review Involving Ocular Management in Cardiac Polypharmacy.” Optometry, 73(2), 113-121.

Chrischilles, E.A., Carter, B.L., Lund, B.C., Rubenstein, L.M., Chen-Hardee, S.S., Voelker, M.D., Park, T., and Kuehl, A.K. (2004). “Evaluation of the Iowa Medicaid Pharmaceutical Case Management Program.” Journal of the American Pharmacists Association, 44(3), 337-349.

Chisholm, M.A., and Hawkins, D.W. (1996). Analysis of Pharmacotherapy Recommendations Provided by Doctor of Pharmacy Clerkship Students.” J Pharm Teach, 5, 3-12.

Chisholm, M.A., Taylor, A.T., and Hawkins, D.W. (1997). “Pharmaceutical Care Provided by Doctor of Pharmacy Clerkship Students in Geriatric Patients in an Acute Care Setting.” J Ger Ther, 11, 43-50.

Clarkson, J.E., Gordon, A.M., and Logan, B.K. (2004). “Lorazepam and Driving Impairment.” J. Anal. Toxicol. 28:475-480.

Coons, S.J. (2001). “Medication Compliance: the Search for Answers Continues.” Clin Ther, 23, 1294-1295.

Cramer, J.A. (2004). “The Usefulness of Medication Compliance Data in Interpretation of Outcomes.” Yale University School of Medicine, Connecticut. Accessed on November 29, 2004, at http://hiv.buffalo.edu/medcompliance.shtml.

Curtis, L.H., Østbye ,T., Sendersky, V., Hutchison, S., Dans, P.E., Wright A., Woosley, R.L., and Schulman, KA. (2004). “Inappropriate Prescribing for Elderly Americans in a Large Outpatient Population.” Arch. Intern. Med. 164:1621-1625.

Dahan, A. and Altman, H. (2004). “Food-Drug Interaction: Grapefruit Juice Augments Drug Bioavailability–Mechanism, Extent, and Relevance.” Eur. J. Clin. Nutr. 58:1-9.

Dailey, G., Kim, M.S., and Lian, J.F. (2001). “Patient Compliance and Persistence with antihyperglycemic Drug Regimens: Evaluation of a Medicaid Patient Population with Type 2 Diabetes Mellitus.” Clinical Therapeutics, 23(8), 1311-1320.

Darnell, J.C., Murray, M.D., Martz, B.L., et al. (1986). “Medication Use by Ambulatory Elderly: An In-Home Study.” Journal of the American Geriatrics Society, 34, 1-4.

De Raedt, R., and Ponjaert-Kristoffersen, I. (2001). “Predicting At-Fault Car Accidents of Older Drivers.” Accident Analysis and Prevention, 33, 809-819.

Del R ío, M.C., and Alvarez, F.J. (2003). “Medication and Fitness to Drive.” Pharmacoepidemiology and Drug Safety, 12, 389-394.

Del R ío, M.C., and Alvarez, F.J. (2001). “Illicit Drugs and Fitness to Drive: Assessment in Spanish Medical Driving Test Centres.” Drug and Alcohol Dependence, 64, 19-25.

Del R ío, M.C., G ómez, J., Sancho, M., and Alvarez, F.J. (2002). “Alcohol, Illicit Drugs, and Medicinal Drugs in Fatally Injured Drivers in Spain Between 1991 and 2000.” Forensic Science International, 127, 63-70.

Department of Health. (2001). Medicines and Older People: Implementing Medicines-Related Aspects of the NSF for Older People. London, England. Available at www.gov.uk/nsf/olderpeople.htm.

Diamond, T.H., Collins, J., and Rohl, P. (2005). “Motor Vehicle Accidents During Episodes of Hypoglycaemia—Case Reports and Lessons to be Learnt.” Australian Family Physician, 34(3), 151-154.

Di Stefano, M., and Macdonald, W. (2003). “Assessment of Older Drivers: Relationships Among On-Road Errors, Medical Conditions, and Test Outcome.” Journal of Safety Research, 34, 415-429.

Drummer, O.H., Gerostamoulos, J., Batziris, H., Chu, M., Caplehorn, J., Robertson, M.D., and Swann, P. (2004). “The Involvement Of Drugs In Drivers Of Motor Vehicles Killed In Australian Road Traffic Crashes.” Accid. Anal. Prev. 36:239-248.

Drummer, O.H., Gerostamoulos, J., Batziris, H., Chu, M., Caplehorn, J.R., Robertson, M.D., and Swann, P. (2003). “The Incidence of Drugs in Drivers Killed in Australian Road Traffic Crashes.” Forensic Sci. Int. 134:154-162.

Duchek, J.M., Carr, D.B., Hunt, L., Roe, C.M., Xiong, C., Shah, K., and Morris, J.C. (2003). “Longitudinal Driving Performance in Early-Stage Dementia of the Alzheimer Type.” Journal of the American Geriatrics Society, 51, pp. 1342-1347.

Dunbar-Jacob, J., Bobachick, P., and Sereika, S. (2003). “Medication Adherence in Persons with Cardiovascular Disease.” J Cardiovasc Nurs, 18(3), 209-218.

Ennis, K.J., and Reinhard, R.A. (1997). “Maximizing Drug Compliance in the Elderly.” Post Grad Medical Journal, 102, 21-212.

Etminan, M., Hemmelgarn, B., Delaney, J.A., and Suissa, S. (2004). Use Of Lithium and “The Risk of Injurious Motor Vehicle Crash in Elderly Adults: Case-Control Study Nested Within a Cohort.” Brit. Med. J. 328:558-559.

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA, 1999). Literature Review on the Relation Between Drug Use, Impaired Driving, and Traffic Accidents. Lisbon, Portugal.

Farris, K.B., Ganther-Urmie, J.M., Fang, G., Doucette, W.R., Brooks, J.M., Klepser, D.K., Fries, D.J., and Kuhle, C.L. (2004). “Population-Based Medication Reviews: A Descriptive Analysis of the Medication Issues Identified in a Medicare Not-for-Profit Prescription Discount Program.” The Annals of Pharmacotherapy, 38, 1823-1829.

Feiner, L.A., Younge, B.R., Kazmier, F.J., et al. (1987). “Optic Neuropathy and Amiodarone Therapy.” Mayo Clinic Proceedings, 62, 702-717.

Fick, D.M., Cooper, J.W., Wade, W.E., Waller, J.L., Maclean, J.R., and Beers, M.H. (2003). “Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults: Results of a U.S. Consensus Panel of Experts.” Arch. Intern. Med. 163:2716-2724.

Fillit, H.M., Futterman, R., Orland, B.I., Chim, T., Susnow, L., Picariello, G.P., Scheye, E.C., Spoeri, R.K., Roglieri, J.L., and Warburton, S.W. (1999). “Polypharmacy Management in Medicare Managed Care: Changes in Prescribing by Primary Care Physicians Resulting from a Program Promoting Medication Revies.” The American Journal of Managed Care, 5(5), 587-594.

Fink, A., Morton, S.C., Beck, J.C., Hays, R.D., Spritzer, K., Oishi, S., and Moore, A.A. (2002). “The Alcohol-Related Problems Survey: Identifying Hazardous and Harmful Drinking in Older Primary Care Patients.” Journal of the American Geriatrics Society, 50, 1717-1722.

Foster, E., Hillegass, L.J., and Phillips, S.L. (2004). “Demonstration Program: An Interdisciplinary Approach at a Falls and Mobility Clinic.” Annals of Long-Term Care, 12(5), 27-32.

Fishbain, D.A., Cutler, R.B., Rosomoff, H.L., and Rosomoff, R.S. (2003). “Are Opioid-Dependent/Tolerant Patients Impaired in Driving-Related Skills: A Structured Review. Journal of Pain and System Management, 25(6), 559-577.

Foster, E., Hillegass, L., and Phillips, S. (2004). “Demonstration Program: An Interdisciplinary Approach at a Falls and Mobility Clinic.” Annals of Long-Term Care, 12(5), 27-32.

Freml, J.M., Farris, K.B., Fang, G., and Currie, J. (2004). “Iowa Priority’s Brown Bag Medication Reviews: A Comparison of Pharmacy Students and Pharmacists.” American Journal of Pharmaceutical Education, 68(2) article 50.

Freund, B., Gravenstein, S., Ferris, R., and Shaheen, E. (2002). “Evaluating Driving Performance of Cognitively Impaired and Healthy Older Adults: A Pilot Study Comparing On-Road Testing and Driving Simulation. Journal of the American Geriatrics Society, 50, 1309-1310.

Friedman, S.M., Munoz, B., West, S., Rubin, G.S., and Fried, L.P. (2002). “Falls and Fear of falling: Which Comes First? A Longitudinal Prediction Model Suggests Strategies for Primary and Secondary Prevention.” Journal of the American Geriatrics Society, 50, 1329-1335.

Fries, D.J., and Kuhle, C.L. (2004). “Population-Based Medication Reviews: A Descriptive Analysis of the Medication Issues Identified in a Medicare Not-for-Profit Prescription Discount Program.” Annals of Pharmacotherapy, 38:1823-1829.

Gilbert, J.R., Evans, C.E., Haynes, R.B., et al. (1980). “Predicting Compliance with a Regimen of Digoxin Therapy in Family Practice.” Can Med Assoc J, 123, 119-122.

Goldberg, D., and Williams, P. (1988). A User’s Guide to the GHQ. NFER-Nelson, Windsor.

Gorski, J.C., Vannaprasaht, S., Hamman, M.A., Ambrosius, W.T., Bruce, M.A., Haehner-Daniels, B., and Hall, S.D. (2003). “The Effect of Age, Sex, and Rifampin Administration on Intestinal and Hepatic Cytochrome P450 3A Activity.” Clinical Pharmacology and Therapeutics, 74, 275-287.

Goulding, M.R. (2004). “Inappropriate Medication Prescribing for Elderly Ambulatory Care Patients.” Arch. Intern. Med. 164:305-312.

Granas, A.G., and Bates, I. (1999). “The Effect of Pharmaceutical Review of Repeat Prescriptions in General Practice.” The International Journal of Pharmacy Practice, 7, 264-275.

Gray, S.L., Eggen, A.E., Blough, D., Buchner, D., and LaCroix, A.Z. (2003). “Benzodiazepine Use In Older Adults Enrolled In A Health Maintenance Organization.” American Journal of Geriatric Psychiatry 11:568-576.

Greenblatt, D.J., Harmatz, J.S., von Moltke, L.L., Wright, C.E., and Shader, R.I. (2004). “Age and Gender Effects on the Pharmacokinetics and Pharmacodynamics of Triazolam, a Cytochrome P450 3A Substrate.” Clinical Pharmacology and Therapeutics, 76, 467-479.

Greene, H.L., Graham, E.L., Werner, J.A., et al. (1983). “Toxic and Therapeutic Effects of Amiodarone in the Treatment of Cardiac Arrhythmias.” Journal of the American College of Cardiology, 2, 1114-1128.

Guidelines for the Prevention of Falls in Older Persons (2001).” American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention.” Journal of the American Geriatrics Society, 49, 664-672.

“Guidelines on Psychotropic Drugs for the EC: Clinical Investigation of Medicinal Products in the Treatment of Generalized Anxiety Disorder, Panic Disorder, and Obsessive-Compulsive Disorder.” (1995). Eur Neuropsychopharmacol, 5, 151-155.

Gurwitz, J.H. (2004). “Polypharmacy: A New Paradigm or Quality Drug Therapy in the Elderly?” Archives of Internal Medicine, 164, 18, 1957-1959.

Gurwitz, J.H., Field, T.S., Harrold, L.R., Rothschild, J., Debellis, K., Seger, A.C., Cadoret, C., Fish, L.S., Garber, L., Kelleher, M., and Bates, D.W. (2003). “Incidence and preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting.” Journal of the American Medical Association, 289(9), 1107-1116.

Hanlon, J.T., Schmader, K.E., Boult, C., Artz, M.B., Gross, C.R., Fillenbaum, G.G., Ruby, C.M., and Garrard, J. (2002). “Use of Inappropriate Prescription Drugs by Older People.” Journal of the American Geriatric Society, 50, 26-34.

Harris, L., McKenna, W.J., Rowland, E., et al., (1983). “Side Effects and Possible Contraindications of Amiodarone Use,” American Heart Journal, 106(4 pt 2), 916-922.

Harvard Health Letter. (2004). “Bad Combinations. Drug Interactions You and Your Doctor Need To Worry About.” Harvard Health Letter, 29(6), 1-2.

Hennessy, S., Bilker, W.B., Weber, A., and Strom, B.L. (2002). “Descriptive Analyses of the Integrity of a U.S. Medicaid Claims Database.” Pharmacoepidemiology and Drug Safety, 12, 103-111.

Herrlinger, C., and Klotz, U. (2001). “Drug Metabolism and Drug Interactions in the Elderly.” Best Practice & Research Clinical Gastroenterology , 15:897-918.

Hogan, D.B., Ebly, E.M., and Fung, T.S. (1995). “Regional Variations in Use of Potentially Inappropriate Medications by Canadian Seniors Participating in the Canadian Study of Health and Aging.” Canadian Journal of Clinical Pharmacology, 2, 167-174.

Hogan, D.B., Maxwell, C.J., Fung, T.S., and Ebly, E.M. (2003). “Prevalence and Potential Consequences of Benzodiazepine Use in Senior Citizens: Results from the Canadian Study of Health and Aging.” Canadian Journal of Clinical Pharmacology, 10(2), 72-77.

Honig, A., Arts, B.M., Ponds, R.W., and Riedel, W.J. (1999). “Lithium Induced Cognitive Side-Effects In Bipolar Disorder: A Qualitative Analysis And Implications For Daily Practice.” Int. Clin. Psychopharmacology, 14:167-171.

Hunt, L., Morris, J.C., Edwards, D., et al. (1993). “Driving Performance in Persons with Mild Dementia of the Alzheimer Type.” Journal of the American Geriatrics Society, 41, pp. 747-753.

Ingram, D.V. (1983). “Ocular Effects in Long-Term Amiodarone Therapy.” American Heart Journal, 106 (4 pt 2), 902-905.

Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice. (1990). Clinical Practice Guidelines: Directions for a New Program. National Academy Press, Washington, D.C.

Jainkittivong, A., Aneksuk, V., and Langlais, R.P. (2004). “Medical Health and Medication Use in elderly Dental Patients.” The Journal of Contemporary Dental Practice, 5,(1), 1-10.

Janke, M.K. (2001). “Assessing Older Drivers: Two Studies.” Journal of Safety Research, 32, 43-74.

Janke, M.K., and Hersch, S.W. (1997). Assessing the Older Driver: Pilot Studies. California Department of Motor Vehicles, Report No. 172. Sacramento, CA.

Johnson, R.E., and Ried, L.D. (1996). “ OTC Drug Use In An HMO: Comparing The Elderly And Younger Adults.” Journal of Aging and Health, 8(1), 114-135.

Jones, R.K., Shinar, D., and Walsh, J.M. (2003). State of Knowledge of Drug-Impaired Driving. U.S.DOT/National Highway Traffic Safety Administration Publication No. DOT HS 809 642. Washington, D.C.

Joo, J.H., Lenze, E.J., Mulsant, B.H., Begley, A.E., Weber, E.M., Stack, J.A., Mazumdar, S., Reynolds, C.F. 3 rd, and Pollock, B.G. (2002). “Risk Factors For Falls During Treatment Of Late-Life Depression.” J. Clin. Psychiatry 63:936-941.

Jörgensen, T., Johansson, S., Kennerfalk, A., Wallander, M., and Svärddudd, K. (2001). “Prescription Drug Use, Diagnoses, and Healthcare Utilization Among the Elderly.” The Annals of Pharmacotherapy, 35, 1004-1009.

Kamal-Bahl, S.J., Doshi, J.A., Stuart, B.C., and Briesacher, B.A. (2003). “Propoxyphene Use by Community-Dwelling and Institutionalized Elderly Medicare Beneficiaries.” Journal of the American Geriatrics Society, 51, 1099-1104.

Kaplan, R.C., Bhalodkar, N.C., Brown, E.J., White, J., and Brown, D.L. (2004). “Race, Ethnicity, and Sociocultural Characteristics Predict Noncompliance with Lipid-Lowering Medications.” Preventive Medicine, 39(6), 1249-1255.

Katona, C.L. (2001). “Psychotropics and Drug Interactions In The Elderly Patient.” International Journal of Geriatric Psychiatry, 16, Suppl. 1:S86-S90.

Keene, J.J. Jr., Galasko, G.T., and Land, M.F. (2003). “Antidepressant Use in Psychiatry and Medicine: Importance for Dental Practice.” J. Am. Dent. Assoc. 134:71-79.

Keller, M., Kesselring, J., and Hiltbrunner, B. (2003). “Fitness to Drive with Neurological Disabilities.” Neurorehabiltation and Neural Repair, 17(3), 168-174.

Kennedy, R.L., Henry, J., Chapman, J., Nayar, R., Grant, P., and Morris, A.D. (2002). “Accidents in Patients with Insulin-Treated Diabetes: Increased Risk of Low-Impact Falls But Not Motor Vehicle Crashes—A Prospective Register-Based Study. The Journal of Trauma, Injury, Infection, and Critical Care, 52(4), 660-666.

Kennerfalk, A., Ruig ómez, A., Wallander, M., Wilhelmsen, L., and Johansson, S. (2002). “Geriatric Drug Therapy and healthcare Utilization in the United Kingdom.” The Annals of Pharmacotherapy, 36, 797-803.

Kinirons, M.T., and O'Mahony, M.S. (2004). “Drug Metabolism and Ageing.” Br. J. Clin. Pharmacol. 57:540-544.

Klein, R., Klein, B.E.K., Moss, S.E., Davis, M.D., and DeMets, D.L. (1988). “Glycoslated hemoglobin predicts the incidence and progression of diabetic retinopathy.” Journal of the American Medical Association, 260, pp. 2864-2871.

de Klerk, E., van der Heijde, D., Landewe, R., van der Tempel, H., and van der Linden, S. (2003). “The Compliance-Questionnaire-Rheumatology Compared with Electronic Medication Event Monitoring: A Validation Study.” The Journal of Rheumatology, 30(11), 2469-2475.

de Klerk, E., van der Heijde, D., van der Tempel, H., and van der Linden, S. (1999). “Development of a Questionnaire to Investigate Patient Compliance with Antirheumatic Drug Therapy.” The Journal of Rheumatology, 26, 2635-2641.

Kogos, S.C. (2004). “Support Groups and Treatment Adherence in a Geriatric Outpatient Clinic.” Journal of Clinical Psychology in Medical Settings, 11:4, 275-282.

Kriska, J., and Ross, S. (2002). “Medication Review: Whose Job is It?” The International Journal of Pharmacy Practice, 10 (suppl): R86.

Kurzthaler, I., Wambacher, M., Golser, K., Sperner, G., Sperner-Unterweger, B., Haidekker, A., Pavlic, M., Kemmler, G., and Fleischhacker, W.W. (2003). “Alcohol and/or Benzodiazepine Use in Injured Road Users.” Human Psychopharmacol. 18:361-367.

Lamy, P.P. (1988). “Actions of Alcohol and Drugs in Older Adults.” Generations, Summer, 9-13.

Lane, C.J., Bronskill, S.E., Sykora, K., Dhalla, I.A., Anderson, G.M., Mamdani, M.M., Gill, S.S., Gurwitz, J.H., and Rochon, P.A. (2004). “Potentially Inappropriate Prescribing in Ontario Community-Dwelling Older Adults and Nursing Home Residents.” Journal of the American Geriatrics Society, 52, 861-866.

Lawlor, D.A., Patel, R., and Ebrahim, S. (2003). “Association between falls in elderly women and chronic diseases and drug use: cross sectional study.” BMJ, 327, 712-717.

Lazow, R.B. (2001). “Alcohol and Other Drug Problems in Older Adults: Health and Human Service Professionals Need to Be Aware.Journal of Prevention and Intervention in the Community, 21(1), 79-96.

Lee, R.D. (1998). “Polypharmacy: A Case Report and New Protocol for Management.” Journal of the American Board of Family Practitioners, 11(2), 140-144.

Lee, H.C., Drake, V., and Cameron, D. (2002). “Identification of Appropriate Assessment Criteria to Measure Older Drivers’ Driving Performance in Simulated Driving.” Australian Occupational Therapy Journal, 49, 138-145.

Lee, H.C., Lee, A.H., Cameron, D., and Li-Tsang, C. (2003). “Using a Driving Simulator to Identify Older Drivers at Inflated Risk of Motor Vehicle Crashes.” Journal of Safety Research, 34, 453-459.

Leipzig, R.M., Cumming, R.G., and Tinetti, M.E. (1999). “Drugs and Falls in Older People: A Systematic Review and Meta-Analysis, I, Psychotropic Drugs.” Journal of the American Geriatrics Society, 47, 30-39.

Leipzig, R.M., Cumming, R.G., and Tinetti, M.E. (1999). “Drugs and Falls in Older People: A Systematic Review and Meta-Analysis, II, Cardiac and Analgesic Drugs.” Journal of the American Geriatrics Society, 47, 40-50.

LeRoy, A. (2004). Draft Report: Exploratory Study of the Relationship Between Multiple Medicines and Vehicle Crashes—Analysis of Databases. Unpublished manuscript, IATROGEN, Herndon, VA.

Leveille, S.G., Buchner, D.M., Koepsell, T.D., McCloskey, L.W., Wolf, M.E., and Gagner, E.H. (1994). “Psychoactive Medications and Injurious Motor Vehicle Collisions Involving Older Drivers.” Epidemiology, 5, pp. 591-598.

Levenson, R. (2002). Medication Reviews – The Views of Patients. A Report to the Medicines Partnership. Available at www.medicines-partnership.org/medication-review.

Linjakumpu, T., Hartikainen, S., Klaukka, T., Kivelä, S., and Isoaho, R. (2002). “Psychotropics Among the Home-Dwelling Elderly—Increasing Trends.” Journal of Geriatric Psychiatry, 17, 874-883.

Linjakumpu, T., Hartikainen, S., Klaukka, T., Veijola, J., Kivelä, S., and Isoaho, R. (2002). “Use of Medications and Polypharmacy Are Increasing Among the Elderly.” Journal of Clinical Epidemiology, 55, 809-817.

Liu, H., Golin, C.E., Miller, L.G., Hats, R.D., Beck, C.K., Sanandaji, B.S., et al. (2001). “A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors.” Annals of Internal Medicine, 134, 968-977.

Lyman, J.M., McGwin, G. Jr., and Sims, R.V. (2001). “Factors Related to Driving Difficulty and Habits in Older Drivers.” Accid. Anal. Prev. 33:413-421.

Macaluso, D.C., Shults, W.T., and Fraunfelder, F.T. (1999). “Features of Amiodarone-Induced Optic Neuropathy.” American Journal of Ophthalmology, 127, 610-612.

Mackie, C.A., Lawson, D.H., Campbell, A., Maclaren, A.G., and Waigh, R.A. (1999). “A Randomized Controlled Trial of Medication Review in Patients Receiving Polypharmacy in General Practice.” Pharm J, 263, R7.

MacRae, F., Lowrie, R., MacLaren, A., Kinn, S., and Fish, A. (2003). “Patient Views of Pharmacist-Led Medication Review Clinics: A Preliminary Qualitative Study.” The International Journal of Pharmacy Practice. September, 11:R6.

Mallon, K., and Wood, J.M. (2004). “Occupational Therapy Assessment of Open-Road Driving Performance: Validity of Directed and Self-Directed Navigational Instructional Components.” The American Journal of Occupational Therapy, 58, 279-286.

Mantyjarvi, M., Tuppurainen, K., and Ikaheimo, K. (1998). “Ocular Side Effects of Amiodarone.” Surv Ophthalmol, 42, 360-366.

Mäntyselka, P., Ahonen, R., Viinamäki, H., Takala, J., and Kumpusalo, E. (2002). “Drug Use by Patients Visiting Primary Care Physicians Due to Nonacute Musculoskeletal Pain.” European Journal of Pharmaceutical Sciences, 17, 201-206.

Marinker, M., Blenkinsopp, A., Bond, C. et al. (1997). From Compliance to Concordance: Achieving Shared Goals in Medicine Taking. London, UK: Royal Pharmaceutical Society of Great Britain. http://www.medicines-partnership.org/about-us/history.

Martínez-Sellés, M., García Robles, J.A., Muñoz, R., Serrano, J.A., Frades, E., Dominguez Muñoa, M., and Almendra,l J. (2004). “Pharmacological Treatment in Patients with Heart Failure: Patients Knowledge and Occurrence of Polypharmacy, Alternative Medicine and Immunizations.” Eur. J. Heart Fail. 6:219-226.

McGwin, G. Jr., Sims, R.V., Pulley, L., and Roseman, J.M. (2000). “Relations Among Chronic Medical Conditions, Medications, and Automobile Crashes in the Elderly: A Population-Based Case-Control Study.” Am. J. Epidemiol. 152:424-431.

Memmott, J.L. (2003). “Social Work Practices with the Elderly Substance Abuser.” Journal of Social Work Practice in the Addictions, 3(2), 85-103.

Michocki, R.J. (2001). “Polypharmacy and Principles of Drug Therapy.” In: Daly, M.P., Weiss, B.D., and Adelman, A.M. (eds.) 20 Common Problems in Geriatrics. New York: McGraw-Hill, 69-81.

Michon, J.A. (1985). “A critical view of driver behavior models: What do we know, what should we do?” In L. Evans and R. Schwing, editors, Human Behavior and Traffic Safety. New York: Plenum Press, Pp. 485-520

Mills, K.C., Parkman, K.M., and Spruill, S.E. (1996). “A PC-Based Software Test for Measuring Alcohol and Drug Effects in Human Participants.” Alcoholism: Clinical and Experimental Research, 20(9) 1582-1591.

Mills, S.C., Spruill, S.E., Kanne, R.W., Parkman, K.M., and Zhang, Y. (2001). “The Influence of Stimulants, Sedatives, and Fatigue on Tunnel Vision: Risk Factors for Driving and Piloting.” Human Factors, 43(2), 310-327.

Morisky, D.E., Green, L.W., and Levine, D.M. (1986). “Concurrent and Predictive Validity of a Self-Reported Measure of Medication Adherence.” Med Care, 24, 67-74.

Morland, J. (2000). “Driving Under the Influence of Non-alcoholic Drugs.” Forensic Science Review, 12, 80-105.

Morrow, D., Leiter, V., Shekih, J. (1988). “Adherence and Medication Instructions.” Journal of the American Geriatrics Society, 36, 1147-1160.

Movig, K.L., Mathijssen, M.P., Nagel, P.H., van Egmond, T., de Gier, J.J., Leufkens, H.G., and Egberts, A.C. (2004). “Psychoactive Substance Use and the Risk of Motor Vehicle Accidents.” Accid. Anal. Prev. 36:631-636.

Murray, M.D., Morrow, D.G., Weiner, M., Clark, D.O., Tu, W., Deer, M.M., Brater, C., and Weinberger, M. (2004). “A Conceptual Framework to Study Medication Adherence in Older Adults.” The American Journal of Geriatric Pharmacotherapy, 2(1), 36-43.

Nankoong, K., Farren, C.K., O’Connor, P.G., and O’Mally, S.S. (1999). “Measurement of Compliance with Naltexone in the Treatment of Alcohol Dependence: Research and Clinical Implications. Journal of Clinical Psychiatry, 60(7), 449-453.

Nathan, A., Goodyer, L., Lovejoy, A., and Rashid, A. (1999). “Brown Bag Medication Reviews as a Means of Optimizing Patients’ Use of Medication and of Identifying Potential Clinical Problems. Family Practice, 16, 278-282.

NHS. (2000). “Prescribing for the Older Person.” MeReC Bulletin, 11 (10), 37-40.

Nielsen, C.E., Andrasen, F., Bjerregaard, P. (1983). “Amiodarone Induced Cornea Ventricillata.” Acta Ophthalmol (Copenh), 61, 478-480.

Odenheimer, G.L., Beaudet, M., Jette, A.M., Albert, M.S., Grande, L., and Minaker, K.L. (1994). “Performance-Based Driving Evaluation of the Elderly Driver: Safety, Reliability, and Validity.” Journal of Gerontology: Medical Sciences, 49, M153-M159.

O’Hanlon, J.F., Brookhuis, K.A., Louwerens, J.W., et al. (1986). “Performance Testing as a Part of Drug Registration.” In Drugs and Driving, Eds. J.F. O’Hanlon, J.J. De Gier, Taylor and Francis: London, UK, pp. 311-320.

Oliver, J., and Seymour, A. (1998). “The Role of Drugs and Alcohol in Drivers Fatally Injured in the Strathclyde Police Region of Scotland, 1995-1997. “ In: Proceedings of the Paper Presented at Nordic Conference on Andre Stoffer end Alkohol j Traffiken. Copenhagen.

Ory, M.G., Lipman, P.D., Karlen, P.L., Gerety, M.B., Stevens, V.J., Singh, M.A., Buchner, D.M., Schectman, K.B., and FICSIT Group. (2002). “Recruitment of Older Participants in Frailty/Injury Prevention Studies.” Prevention Science, 3(1), 1-22.

Petty, D.R., Knapp, P., Raynor, D.K., and O’house, A. (2003). “Patients’ Views of a Pharmacist-Run Medication Review Clinic in General Practice.” British Journal of General Practice, 53, 607-613.

Petty, D.R., Zermansky, A.G., Raynor, D.K., Vail, A., Lowe, C.J., Freemantle, N., and Buttress, A.D. (2001). “No Thank You: Why Elderly Patients Declined to Participate in a Research Study.” Pharm World Sci, 23(1), 22-27.

Pharmacy Practice and Medicines Management Group. (2002). Medication Review Patient Invitee Letters. Produced on behalf of the Task Force on Medicines Partnership. Available at www.medicines-partnership.org/medication-review/room-for-review/toolkit/invitations.

Piltz, J.R., Wertenbaker, C., Lance, S.E., et al., (1993). “Digoxin Toxicity: Recognizing the Varied Visual Presentations. Journal of Clinical Neuroophalmology, 13, 275-280.

Pollow, R.L., Stoller, E.P., Forster, L.E., and Duniho, T.S. (1994). “Drug Combinations and Potential for Risk for Adverse Drug Reaction Among Community-Dwelling Elderly.” Nursing Research, 43(1), 44-49.

Pozzato, G., Moretti, M., Franzin et al. (1995). “Ethanol Metabolism and Aging: The Role of ‘ First Pass Metabolism’ and Gastric Alcohol Dehydrognase Activity.” Journal of Gerontology, 50, B135-141.

Quebec Health Insurance Board. (1992). Régie de l’assurance-maladie du Québec. (1992). Rapport du Comité d’analyse de la consommation médicamenteuse des personnes agées. Québec (QC). The Gouvernment de Quebec.

Raeder, E.A., Podrid, P.J., and Lowan, B. (1985). “Side Effects and Complications of Amiodarone Therapy. American Heart Journal, 109(5 Pt 1), 975-983.

Raji, M.A., Ostir, G.V., Markides, K.S., Espino, D.V., and Goodwin, J.S. (2003). “Potentially Inappropriate Medication Use by Elderly Mexican Americans.” The Annals of Pharmacotherapy, 37, 1197-1202.

Ramaekers, J. (2003). “Antidepressants and Driver Impairment: Empirical Evidence from a Standard On-the-Road Test.” Journal of Clinical Psychiatry, 64(1), 20-29.

Ramaekers, J.G., Berghaus, G., van Laar, M., and Drummer, O.H. (2004). “Dose Related Risk of Motor Vehicle Crashes after Cannabis Use.” Drug and Alcohol Dependence, 73, 109-119.

de Rekeneire, N., Visser, M., Peila, R., Nevitt, M., Cauley, J., Tylavsky, F., Simonsick, E., and Harris, T. (2003). “Is a Fall Just a Fall: Correlates of Falling in Healthy Older Persons. The Health, Aging, and Body Composition Study.” Journal of the American Geriatrics Society, 51, 841-846.

Richardson, E.D., and Marottoli, R.A. (2003). “Visual Attention and Driving Behaviors Among Community-Living Older Persons.” Journal of Gerontology Series A: Biological Sciences and Medical Sciences, 58:M832-M836.

Riefkohl, E.Z., Bieber, H.L., Burlingame, M.B., and Lowenthal, D.T. (2003). “Medications and Falls in the Elderly: A Review of the Evidence and Practical Considerations.” Pharm. Therap., P&T 28:724-726, 733.

Roe, C.M., Anderson, M.J., and Spivack, B. (2002). “How Many Patients Complete an Adequate Trial of Donepezil?” Alzheimer Disease and Associated Disorders, 16(1), 49-51.

Roe, C.M., Anderson, M.J., and Spivack, B. (2002). “Use of Anticholinergic Medications by Older Adults with Dementia.” J. Am. Geriatr. Soc. 50:836-842.

Roenker, D.L., Cissell, G.M., Ball, K.K., Wadley, V.G., and Edwards, J.D. (2003). “Speed-of-processing and driving simulator training result in improved driving performance.” Human Factors, 45(2), 218-233. Slaughter, R.L., Erickson, S.R., and Thomson, P.A. (1994). “Clinical Interventions Provided by Doctor of Pharmacy Students. Ann Pharmacother, 28, 665-669.

RxMed. (2005). The Comprehensive Resource for Physicians, Drug, and Illness Information. www.rxmed.com

Salom, I.L., and Davis, K. (1995). “Prescribing for Older Patients: How to Avoid Toxic Drug Interactions.” Geriatrics, 50(10), 37-45.

Samet, J.H., Sullivan, L.H., Traphagen, E.T., and Ickovics, J.R. (2001). “Measuring Adherence Among HIV-Infected Persons: Is MEMS Consummate Technology? Aids and Behavior, 5, 21-30.

Schmucker, D.L. (2001). “Liver Function and Phase I Drug Metabolism in the Elderly: A Paradox.” Drugs Aging 18:837-851.

Shalansky, S.J., and Levy, A.R. (2002). “Effect of Number of Medications on Cardiovascular Therapy Adherence.” The Annals of Pharmacotherapy, 36, 1532-1539.

Sheikh, J.I. (2004). “Anxiolytics, Sedatives, and Older Patients.” Primary Psychiat. 11:51-54.

Slaughter, R.L., Ericson, S.R., and Thomson, P.A. (1994). “Clinical Interventions Provided by Doctor of Pharmacy Students.” The Annals of Pharmacotherapy, 28, 665-669.

Smith, M., and Joseph, G. (2003). “Pharmacy Data in the VA Health Care System. Medical Care Research and Review, 60(3), Supplement to September 2003, 92S-123S. Available at www.herc.research.med.va.gov/pharmacy%20data.pdf.

Spagnoli, A., Ostino, G., Borga, A.D., et al. (1989). “Drug Compliance and Underreported Drugs in the Elderly.” Journal of the American Geriatrics Society, 37, 619-624.

Spina, E., and Scordo, M.G. (2002). “Clinically Significant Drug Interactions with Antidepressants in the Elderly.” Drugs Aging 19:299-320.

Sreih, A.G., Schonfield, M.H., Marieb, M.A. (1999). “Optic Neuropathy following Amiodarone Therapy.” Pacing Clinical Electrophysiology, 22, 1108-1110.

Staplin, L., Lococo, K., McKnight, A.J., McKnight, A.S., and Odenheimer, G. (1998). Intersection Negotiation Problems of Older Drivers, Volume II: Background Synthesis on Age and Intersection Driving Difficulties. National Highway Traffic Safety Administration Publication No. DOT HS 808 850. Washington, DC.

Staplin, L., Lococo, K., Stewart, J., and Decina, L. (1999). Safe Mobility for Older People Notebook. National Highway Traffic Safety Administration Publication No. DOT HS 808 853. Washington, DC.

Steiner, J.F., and Earnest, M.A. (2000). “Lingua Medica: The Language of Medication-Taking.” Annuals of Internal Medicine, 132, 926-930.

Stolze, H., Klebe, S., Zechlin, C., Baecker, C., Friege, L., and Deuschl, G. (2004). “Falls in Frequent Neurological Diseases: Prevalence, Risk Factors, and Aetiology,” Journal of Neurology, 251, 79-84.

Stuck, A.E., Beers, M.H., Steiner, A., Aronow, H.U., Rubenstein, L.Z., and Beck, J.C. (1994). “Inappropriate Medication Use in Community-Residing Older Persons.” Archives of Internal Medicine, 154(19), pp 2195-2200.

Sundet, K., Goffeng, L., and Hofft, E. (1995). “To Drive or Not to Drive: Neuropsyhological Assessment for Driver’s License Among Stroke Patients.” Scandinavian Journal of Psychology, 36(1), 47-58.

Szlyk, J. P., Brigell, M., and Seiple, W. (1993). “Effects of Age and Hemianopic Visual Field Loss on Driving.” Optometry and Vision Science, 70, 1031-1037.

Szlyk, J.P., Mahler, C.L., Seiple, W., Vajaranant, T.S., Blair, N.P., and Shahidi, M. (2004). “Relationship of Retinal Structural and Clinical Vision Parameters to Driving Performance of Diabetic Retinopathy Patients.” Journal of Rehabilitation Research and Development, 41(3A), 347-358.

Szlyk, J. P., Mahler, C. L., Seiple, W., Vajaranant, T. S., Blair, N. P., and Shahidi, M. (2004). “Effects of Retinal Structure and Clinical Vision Parameters on Driving Performance in Diabetic Retinopathy Patients.” Journal of Rehabilitation Research and Development, 41:3 A, 347-357.

Task Force on Medicines Partnership and the National Collaborative Medicines Management Services Programme. (2002). Room for Review: A Guide to Medication Review: the Agenda for Patients, Practitioners, and Managers. London, England.

Taylor, C.T., Church, C.O., and Byrd, D.C. (2000). Documentation of Clinical Interventions by Pharmacy Faculty, Residents, and Students. Ann Pharmacother, 34, 843-846.

Thapa, P.B., Gideon, P., and Cost, T.W. (1998). “Antidepressants and the Risk of Falls Among Nursing Home Residents.” New England Journal of Medicine, 339, 875-82.

Tinetti, M.E. (2004). “Preventing Falls in Elderly Persons.” The New England Journal of Medicine, 348, 42-49.

Treharne, G.J., Lyons, A.C., Kitas, G.D. (2004). “Medication Adherence in Rheumatoid Arthritis: Effects of Psychosocial Factors.” Psychology, Health, and Medicine, 9(3), 338-349.

Vermeeren, A. (2004). “Residual Effects of Hypnotics: Epidemiology and Clinical Implications.” CNS Drugs 18:297-328.

Vik, S.A., Maxwell, C.J., and Hogan, D.B. (2004). “Measurement, Correlates, and Health Outcomes of Medication Adherence Among Seniors.” The Annals of Pharmacotherapy, 38, 303-312.

Walsh, J. M., de Gier, J.J., Christopherson, A.S., and Verstraete, A.G. (2004). “Drugs and Driving.” Traffic Injury Prevention, 5, 241-253.

Wang, P.S., Bohn, R.L., Knight, E., Glynn, R.J., Mogun, H., and Avorn, J. (2002). “Noncompliance with Antihypertensive Medications: The Impact of Depressive Symptoms and Psychosocial Factors.” Journal of General Internal Medicine, 17(7) 504-511.

Weiler, J.M., Bloomfield, J.R., Woodworth, G.G., Grant, A.R., Layton, T.A., Brown, T.L., McKenzie, D.R., Baker, T.W., and Watson, G.S. (2000). “Effects of Fexofenadine, Diphenhydramine, and Alcohol on Driving Performance. A Randomized, Placebo-Controlled Trial in the Iowa Driving Simulator.” Annals of Internal Medicine, 132(5), 354-363.

Wild, K., and Cotrell, V. (2003). “Identifying Driving Impairment in Alzheimer Disease: A Comparison of Self and Observer Reports Versus Driving Evaluation.” Alzheimer Disease and Associated Disorders, 17(1), pp. 27-34.

Wilkinson, C., and Moskowitz, H. (2001). Polypharmacy and Older Drivers: Literature Review. Unpublished Manuscript, Southern California Research Institute, Los Angeles, CA.

Wong, E. (2004). The Polypharmacy Intervention Program. Partnership for Improving Affordability and Quality. BlueWorks Quarterly Application Submission. February 1, 2004.

Wood, J. (2002). “Age and Visual Impairment Decrease Driving Performance as Measured on a Closed-Circuit.” Human Factors, 44(3), 482-494.

World Health Organization. (1975). Requirements for Adverse Reaction Reporting. Geneva.

Zacny, J. (1995). “A Review of the Effects of Opioids on Psychomotor and Cognitive Functioning in Humans.” Experimental and Clinical Psychopharmacology, 3(4), 432-466.

Zautcke, J.L., Coker, S.B., Morris, R.W., and Stein-Spencer, L. (2002). “Geriatric Trauma in the State of Illinois: Substance Use and Injury Patterns.” American Journal of Emergency Medicine, 20(1), 14-17.

Zeeh, J. (2001). The Aging Liver: Consequences for Drug Treatment in Old Age. Arch. Gerontol. Geriatr. 32:255-263.

Zermansky, A.G., Petty, D.R., Raynor, D.K., Freemantle, N., Vail, A., and Lowe, C. (2001). “Randomized Controlled Trial of Clinical Medication Review by a Pharmacist of Elderly Patients Receiving Repeat Prescriptions in General Practice.” BMJ, Dec 8, 323, 1340-1343.

Zhan, C., Sangl, J., Bierman, A.S., Miller, M.R., Friedman, B., Wickizer, S.W., and Meyer, G.S. (2001). “Potentially Inappropriate Medication Use in the Community-Dwelling Elderly: Findings from the 1996 Medical Expenditure Panel Survey.” Journal of the American Medical Association, 286, 2823-2829.

 

Back

Top